TAX-FREE FAMILY ESSENTIALS ACT.

Printer-friendly: Click to view
View NCGA Bill Details2025-2026 Session
House Bill 1200 (Public) Filed Thursday, April 30, 2026
AN ACT TO EXEMPT DIAPERS, BABY WIPES, AND FEMININE HYGIENE PRODUCTS FROM THE SALES TAX.
Intro. by Schietzelt, Rhyne, Campbell, Chesser.

Status: Ref To Com On Rules and Operations of the Senate (Senate action) (Jul 1 2026)

SOG comments (1):

Long title change

Committee substitute to the 1st edition changed the long title. Original long title was AN ACT TO EXEMPT DIAPERS, BABY WIPES, OVER-THE-COUNTER CHILDREN'S MEDICATION, PRENATAL VITAMINS, AND FEMININE HYGIENE PRODUCTS FROM THE SALES TAX.

H 1200

Bill Summaries:

  • Summary date: Jun 30 2026 - View Summary

    House amendment extends the act's effective date from October 1, 2026, to April 1, 2027. 


  • Summary date: Jun 30 2026 - View Summary

    House committee substitute to the 1st edition removes over-the-counter children's medication and prenatal vitamins from the act's new sales tax exclusions in GS 105-164.13. Makes additional clarifying changes. Makes a conforming deletion of the definition of prenatal vitamins in GS 105-164.3. Makes conforming changes to the act's long title.


  • Summary date: May 1 2026 - View Summary

    Amends GS 105-164.13 to exclude from sales tax baby wipes, prenatal vitamins, and feminine hygiene products, as now defined under GS 105-164.3. Excludes grooming and hygiene products from the definition of feminine hygiene products. Further amends GS 105-164.13 to exclude from sales tax sales of diapers or incontinence pads (removing the existing qualification that the sale be on those prescribed by an enrolled State Medicaid/health Choice provider for use by program beneficiaries when the provider is reimbursed by the State Medicaid program or a Medicaid MCO). Adds an exclusion for over-the-counter drugs intended for the treatment of a health condition in children 12 and under and labeled with a Drug Facts panel containing specific dosage instructions for children 12 and under. Applies to sales made on or after October 1, 2026.